Tag: President Joe Biden
-
Shares of Pfizer Just Got a Substantial Boost
There goes Pfizer (PFE). The stock is popping on news it’s buying ReViral – a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV) for $525 million. “Currently, treatment options for RSV are extremely limited and focus primarily on supportive care,” said Annaliesa Anderson,…
-
Use Weakness in SolarEdge as Long-Term Opportunity
Keep an eye on SolarEdge Technologies (SEDG). After crumbling from $371, the stock appears to have caught double bottom support dating back to November 2020. That, and RSI, MACD, and Williams’ %R are all deeply oversold. All thanks to disappointing earnings. While revenue came in at $405 million, beating estimates for $395 million, EPS came…